| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
REPL
Replimune Group
|
Aug 07, 2026 | BUY |
Strong Buy
+66.6% avg upside
14 analysts
|
$20.00
46.40% Upside
|
· | · |
|
SRRK
Scholar Rock Holding
|
Aug 07, 2026 | BUY |
Strong Buy
+10.9% avg upside
23 analysts
|
$76.00
46.55% Upside
|
-1.9% | · |
|
LLY
Eli Lilly & Co
|
Aug 06, 2026 | BUY |
Strong Buy
-14.0% avg upside
48 analysts
|
$1400.00
13.57% Upside
|
-0.5% | · |
|
GPCR
Structure Therapeutics, Inc. Sponsored ADR
|
Aug 06, 2026 | BUY |
Strong Buy
+94.7% avg upside
17 analysts
|
$145.00
169.50% Upside
|
+2.3% | · |
|
GILD
Gilead Sciences
|
Aug 06, 2026 | BUY |
Strong Buy
-10.7% avg upside
66 analysts
|
$174.00
30.86% Upside
|
+1.7% | · |
|
MRK
Merck & Company
|
Aug 05, 2026 | BUY |
Strong Buy
-0.9% avg upside
43 analysts
|
$142.00
8.44% Upside
|
+0.2% | · |
|
SDGR
Schrodinger
|
Aug 05, 2026 | BUY |
Strong Buy
+51.8% avg upside
14 analysts
|
$24.00
27.91% Upside
|
+10.7% | · |
|
BNTX
BioNTech SE
|
Aug 05, 2026 | BUY |
Strong Buy
+43.6% avg upside
26 analysts
|
$128.00
37.86% Upside
|
+1.2% | · |
|
NVO
Novo Nordisk
|
Aug 05, 2026 | HOLD |
Buy
+144.0% avg upside
26 analysts
|
$47.00
1.60% Downside
|
+6.1% | · |
|
AMGN
Amgen
|
Aug 05, 2026 | BUY |
Buy
-23.9% avg upside
57 analysts
|
$450.00
7.94% Upside
|
+2.3% | · |
|
PFE
Pfizer
|
Aug 04, 2026 | BUY |
Buy
+24.0% avg upside
45 analysts
|
$30.00
10.87% Upside
|
+6.5% | · |
|
REGN
Regeneron
|
Jul 31, 2026 | BUY |
Strong Buy
-2.3% avg upside
58 analysts
|
$800.00
0.98% Downside
|
+2.9% | · |
|
BIIB
Biogen
|
Jul 30, 2026 | HOLD |
Strong Buy
+21.9% avg upside
52 analysts
|
$208.00
0.46% Upside
|
+0.0% | · |
|
INCY
Incyte
|
Jul 29, 2026 | HOLD |
Buy
-11.5% avg upside
47 analysts
|
$130.00
6.87% Upside
|
-5.1% | · |
|
MPLT
MapLight Therapeutics, Inc.
|
Jul 27, 2026 | BUY |
Strong Buy
+142.4% avg upside
13 analysts
|
$20.00
64.14% Upside
|
+23.0% | · |
|
BMY
Bristol-Myers Squibb
|
Jul 27, 2026 | HOLD |
Buy
-5.9% avg upside
42 analysts
|
$60.00
7.39% Downside
|
+3.6% | · |
|
NBIX
Neurocrine
|
Jul 13, 2026 | HOLD |
Strong Buy
+14.1% avg upside
37 analysts
|
$170.00
3.13% Upside
|
-6.1% | · |
|
VRTX
Vertex Pharmaceuticals
|
Jul 13, 2026 | BUY |
Strong Buy
-14.3% avg upside
62 analysts
|
$600.00
14.58% Upside
|
+3.3% | · |
|
ABBV
AbbVie
|
Jul 13, 2026 | BUY |
Strong Buy
-3.4% avg upside
46 analysts
|
$300.00
21.03% Upside
|
+0.7% | · |
|
TSE:APTX
Apotex Health Corp.
|
Jul 06, 2026 | BUY |
Strong Buy
+7.2% avg upside
10 analysts
|
$39.00
4.81% Upside
|
+8.0% | · |
|
TSHA
Taysha Gene Therapies
|
Jun 30, 2026 | BUY |
Strong Buy
+116.6% avg upside
21 analysts
|
$14.00
119.73% Upside
|
-6.5% | · |
|
ABCL
AbCellera Biologics
|
Jun 17, 2026 | BUY |
Strong Buy
+57.4% avg upside
15 analysts
|
$7.00
25.05% Downside
|
+27.4% | · |
|
IRON
Disc Medicine
|
Jun 02, 2026 | BUY |
Strong Buy
+11.3% avg upside
21 analysts
|
$100.00
27.77% Upside
|
+13.9% | · |
|
ACAD
ACADIA Pharmaceuticals
|
May 11, 2026 | BUY |
Strong Buy
+24.5% avg upside
43 analysts
|
$34.00
15.76% Upside
|
+16.7% | · |
|
PTGX
Protagonist Therapeutics
|
Oct 13, 2025 | BUY |
Strong Buy
-22.9% avg upside
19 analysts
|
$112.00
25.39% Downside
|
+86.6% | · |
|
NGNE
Neurogene
|
Sep 30, 2025 | HOLD |
Strong Buy
+36.0% avg upside
23 analysts
|
— | +105.9% | · |
|
ARVN
Arvinas Holding Company
|
Sep 30, 2025 | HOLD |
Buy
+220.0% avg upside
28 analysts
|
— | +5.1% | · |
|
CCCC
C4 Therapeutics
|
May 06, 2025 | HOLD |
Strong Buy
+390.2% avg upside
19 analysts
|
— | +164.5% | · |
|
DE:MRK
Merck KGaA
|
Oct 23, 2024 | BUY |
Buy
-4.3% avg upside
33 analysts
|
$129.82
9.55% Downside
|
-3.0% | · |
|
CADL
Candel Therapeutics
|
Aug 07, 2023 | HOLD |
Strong Buy
+73.0% avg upside
11 analysts
|
— | +445.8% | · |
|
NUVB
Nuvation Bio
|
May 09, 2023 | HOLD |
Strong Buy
+103.8% avg upside
15 analysts
|
— | +29.8% | · |
|
IMA
ImageneBio
|
Aug 13, 2021 | BUY |
Buy
+195.4% avg upside
12 analysts
|
$27.00
372.01% Upside
|
· | · |
|
OBX
Obsidian Therapeutics
|
Dec 16, 2020 | BUY |
Buy
-68.8% avg upside
9 analysts
|
$15.00
57.10% Downside
|
· | · |
|
NL:LKFT
Galapagos
|
Oct 16, 2020 | HOLD |
Sell
+122.5% avg upside
16 analysts
|
$129.00
450.24% Upside
|
-59.2% | · |
|
TLPH
Talphera
|
Aug 13, 2020 | SELL |
Buy
+233.3% avg upside
15 analysts
|
$0.84
40.39% Downside
|
· | · |
|
MGNX
MacroGenics
|
May 11, 2020 | BUY |
Buy
+333.9% avg upside
25 analysts
|
$30.00
635.20% Upside
|
-84.4% | · |
|
LKFT
Lakefront Biotherapeutics
|
Feb 24, 2020 | HOLD |
Buy
+293.5% avg upside
24 analysts
|
$220.00
717.62% Upside
|
-73.3% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.